Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).
J Addict Med
; 14(4): e1-e3, 2020.
Article
em En
| MEDLINE
| ID: mdl-32412931
ABSTRACT
The COVID-19 health crisis joined, rather than supplanted, the opioid crisis as the most acutely pressing threats to US public health. In the setting of COVID-19, opioid use disorder treatment paradigms are being disrupted, including the fact that methadone clinics are scrambling to give "take-home" doses where they would typically not. The rapid transition away from in-person examination, dosing and group therapy in an era of social isolation calls for adjustments to clinical practice, including emphasizing patient-provider communication, favoring new inductees on buprenorphine and leveraging technology to optimize safety of medication treatment.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Controle de Infecções
/
Infecções por Coronavirus
/
Centros de Tratamento de Abuso de Substâncias
/
Tratamento de Substituição de Opiáceos
/
Pandemias
/
Antagonistas de Entorpecentes
/
Transtornos Relacionados ao Uso de Opioides
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Addict Med
Ano de publicação:
2020
Tipo de documento:
Article